Skip to content

The Application of Cultured Cornea Stem Cells in Patients Suffering From Corneal Stem Cell Insufficiency

Phase 1 Study of Cornea Stem Cells Cultured on Amniotic Membrane Transplanted on Patients Suffering From Corneal Stem Cell Insufficiency

Status
Terminated
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01377311
Enrollment
0
Registered
2011-06-21
Start date
2008-07-31
Completion date
2010-04-30
Last updated
2011-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unilateral Limbal Stem Cell Insufficiency

Keywords

limbal stem cell, amniotic membrane, ex vivo expansion of autologous limbal stem cell, unilateral limbal stem cell insufficiency

Brief summary

Name of the project:The application of cornea stem cells cultured on amniotic membrane in patients suffering from corneal stem cell insufficiency Purpose: To develop the technique of using ex vivo expansion of autologous limbal stem cell cultured on amniotic membrane for treatment of patients suffering from limbal stem cell insufficiency

Detailed description

Materials and Methods: 1. Patients suffering from unilateral limbal stem cell insufficiency will be chosen. Make sure those volunteers understand the benefits and risk factors of the operation. 2. Prepare human amniotic membrane, and culture the membrane at37°C,5% CO2,95% room air. 3. One month before transplantation, take 1-2mm2 of limbal tissues from the healthy eye, and culture the limbal tissue on amniotic membrane with 1.5 ml supplemental hormonal epithelial medium (in 5%的 fetal calf serum) 4. Keep culturing the cells in Dulbecco's modified Eagle's medium/Ham's F12 (1:1 ratio), added with 5 % dimethyl sulfoxide, 2 mg/ml human epidermal growth factor ,5 ug/ml insulin, 0.5 ug/ml hydrocortisone, 50 ug/ml gentamicin, 1.25 ug/ml amphotericin B, 5% autoserum。Two to three weeks later, transplantation will be performed after the cells reaches 2-3 cm2 5. Remove the abnormal surface tissue on the lesion cornea, transplant the amniotic membrane with cultured limbal stem cells on the denuded cornea. Cover with contact lens after operation, and apply topical antibiotics and steroids. 6. Postoperatively, observe the patients for one week. After discharge, follow up the patients one week, two week, one month, two months, three months, six months and one year later. 7. Pictures will be taken and the extent of corneal epithelium regeneration, visual acuity, and complications will be recorded during follow-up visits. 8. The investigators plan to collect 20 patients from 1 July,2007 to 30, June, 2010

Interventions

PROCEDURETransplant of cultured limbal stem cells on cornea

Remove the abnormal surface tissue on the lesion cornea, transplant the amniotic membrane with cultured limbal stem cells on the denuded cornea. Cover with contact lens after operation, and apply topical antibiotics and steroids.

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* unilateral limbus defect larger than 180 degrees * repeated corneal epithelial ulcer, loss of visual acuity or neovascularization due to limbal stem cell insufficiency * no improvement after medical intervention for more than 6 months * the patient is willing to receive surgery and postoperative follow up

Exclusion criteria

* bilateral limbus defect * limbal stem cell insufficiency does not induce repeated corneal epithelial ulcer, loss of visual acuity or neovascularization * corneal neovascularization deeper than 1/2 depth of surface matrix * peripheral surface matrix is less than 200um thick * no corneal reflex was induced by fiber less than 5mm length measured by Cocet-Bonnet esthesiometer * improvement under medication * perisurgical follow up less than 6 months * unable to be long term followed up postoperatively * glaucoma patients underwent glaucoma surgery, under medication, IOP \> 21mmHg * glaucoma patients underwent glaucoma surgery, under medication, IOP \< 21mmHg, optic disc depression \> 90% * severe incomplete eyelid closure * severe dye eye syndrome, Schirmer test 5 min \< 3 mm * contralateral eye limbus tissue cannot be obtained, or unable to be cultured * pregnant

Design outcomes

Primary

MeasureTime frame
The extent of corneal epithelium regenerationone week, two week, one month, two months, three months, six months and one year later

Secondary

MeasureTime frame
visual acuityone week, two week, one month, two months, three months, six months and one year later
complicationsone week, two week, one month, two months, three months, six months and one year later

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026